These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4156595)

  • 1. Effect of chronic administration of centrally acting compounds on chloramphenicol metabolism in schizophrenic patients.
    Watanabe A
    Pharmacology; 1974; 11(4):253-6. PubMed ID: 4156595
    [No Abstract]   [Full Text] [Related]  

  • 2. Increase of chloramphenicol glucuronidation in rats treated with phenobarbital.
    Stramentinoli G; Gazzaniga A; Della Bella D; Remmer H
    Biochem Pharmacol; 1974 Apr; 23(7):1181-6. PubMed ID: 4823451
    [No Abstract]   [Full Text] [Related]  

  • 3. Chloramphenicol metabolism in the phenobarbital-induced rat. Comparison with thiamphenicol.
    Bella DD; Marca G; Ferrari V; Bonanomi L
    Biochem Pharmacol; 1968 Dec; 17(12):2381-90. PubMed ID: 5720346
    [No Abstract]   [Full Text] [Related]  

  • 4. Elimination of chloramphenicol and thiamphenicol in subjects with cirrhosis of the liver.
    Azzollini F; Gazzaniga A; Lodola E; Natangelo R
    Int J Clin Pharmacol; 1972 Jun; 6(2):130-4. PubMed ID: 4638972
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of chloramphenicol metabolism by phenobarbital.
    Palmer DL; Despopoulos A; Rael ED
    Antimicrob Agents Chemother; 1972 Feb; 1(2):112-5. PubMed ID: 4680801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum levels of chloramphenicol during simultaneous administration of penicillin in children].
    Windorfer A
    Z Kinderheilkd; 1972; 112(1):79-88. PubMed ID: 5019027
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dynamics and treatment of the tendency to enchronization of schizophrenic psychoses].
    López-Ibor Aliño JM
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(2):377-88. PubMed ID: 4147379
    [No Abstract]   [Full Text] [Related]  

  • 8. A pharmacologic study of chloramphenicol in cattle.
    Sisodia CS; Dunlop RH; Gupta VS; Taksas L
    Am J Vet Res; 1973 Sep; 34(9):1147-51. PubMed ID: 4747035
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics, plasma protein binding and dosage of chloramphenicol in cattle and horses.
    Pilloud M
    Res Vet Sci; 1973 Sep; 15(2):231-8. PubMed ID: 4803578
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of phenothiazine withdrawal on proverb interpretation by chronic schizophrenics.
    Chapman LJ; Cameron R; Cocke JG; Pritchett T
    J Abnorm Psychol; 1975 Feb; 84(1):24-9. PubMed ID: 234133
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetic study of chloramphenicol in patients with liver disease.
    Narang AP; Datta DV; Nath N; Mathur VS
    Eur J Clin Pharmacol; 1981; 20(6):479-83. PubMed ID: 7286060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloramphenicol disposition in infants and children.
    Friedman CA; Lovejoy FC; Smith AL
    J Pediatr; 1979 Dec; 95(6):1071-7. PubMed ID: 387936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical blood chemistry values and long acting phenothiazines.
    Schneider SJ; Kirby EJ; Itil TM
    Pharmacopsychiatria; 1981 May; 14(3):107-14. PubMed ID: 6114503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excretion of chloramphenicol and its metabolites by the chronically diseased kidney (with respect to the theory of adaptive nephrons).
    Schück O; Prát V; Grafnetterová J; Kotanová E; Reitschlägerová V; David I
    Int J Clin Pharmacol; 1974 Jul; 10(1):33-43. PubMed ID: 4851956
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of ethacrynic acid, hydrochlorothiazide and clopamide on the renal excretion of chloramphenicol and its metabolites.
    Schück O; Nádvorníková H; Grafnetterová J
    Int J Clin Pharmacol Biopharm; 1978 May; 16(5):217-9. PubMed ID: 649239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioavailability and clearance of chloramphenicol after intravenous chloramphenicol succinate.
    Nahata MC; Powell DA
    Clin Pharmacol Ther; 1981 Sep; 30(3):368-72. PubMed ID: 7273601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An uncontrolled clinical study with piperacetazine in the maintenance treatment of chronic schizophrenic patients.
    Amin MM; Brahm E; Ban TA; Lehmann HE
    Psychopharmacol Bull; 1977 Jul; 13(3):10-1. PubMed ID: 18753
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on absorption kinetics of different brands of chloramphenicol.
    Lakshamana M; Seth SD; Shriniwas E; Arora RB
    Indian J Med Res; 1973 Jan; 61(1):138-44. PubMed ID: 4585703
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavioral Effects of Reducing the Daily Frequency of Phenothiazine Administration.
    Callahan EJ; Alevizos PN; Teigen JR; Newman H; Campbell MD
    Arch Gen Psychiatry; 1975 Oct; 32(10):1285-90. PubMed ID: 241307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.